Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation

AT Nies, E Schaeffeler, M Schwab - Pharmacology & Therapeutics, 2022 - Elsevier
Organic cation transporters (OCT), organic anion transporting polypeptides (OATP) and
organic anion transporters (OAT) from the solute carrier (SLC) family play an essential role …

Pharmacogenomic studies of current antidiabetic agents and potential new drug targets for precision medicine of diabetes

Z Zeng, SY Huang, T Sun - Diabetes Therapy, 2020 - Springer
Diabetes is a major threat to people's health and has become a burden worldwide. Current
drugs for diabetes have limitations, such as different drug responses among individuals …

Potential impact of microRNA gene polymorphisms in the pathogenesis of diabetes and atherosclerotic cardiovascular disease

I Elfaki, R Mir, MM Mir, FM AbuDuhier… - Journal of personalized …, 2019 - mdpi.com
MicroRNAs (miRNAs) are endogenous, small (18–23 nucleotides), non-coding RNA
molecules. They regulate the posttranscriptional expression of their target genes. MiRNAs …

The impact of genetic polymorphisms in organic cation transporters on renal drug disposition

Z Zazuli, NJCB Duin, K Jansen, SJH Vijverberg… - International journal of …, 2020 - mdpi.com
A considerable number of drugs and/or their metabolites are excreted by the kidneys
through glomerular filtration and active renal tubule secretion via transporter proteins …

Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta …

A Peng, C Gong, Y Xu, X Liang, X Chen… - Frontiers in Public …, 2023 - frontiersin.org
Background Variants in organic cation transporter (OCT) genes play a crucial role in
metformin pharmacokinetics and are critical for diabetes treatment. However, studies …

[HTML][HTML] Metformin and insulin-resistant related diseases: Emphasis on the role of microRNAs

N Alimoradi, N Firouzabadi, R Fatehi - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Metformin is one of the most prescribed drugs in type II diabetes (T2DM) which has recently
found new applications in the prevention and treatment of various illnesses, from metabolic …

Circulating microRNAs signature for predicting response to GLP1-RA therapy in type 2 diabetic patients: a pilot study

C Formichi, D Fignani, L Nigi, GE Grieco… - International Journal of …, 2021 - mdpi.com
Type 2 diabetes (T2D) represents one of the major health issues of this century. Despite the
availability of an increasing number of anti-hyperglycemic drugs, a significant proportion of …

Glucose metabolism-related gene polymorphisms as the risk predictors of type 2 diabetes

C Li, Y Yang, X Liu, Z Li, H Liu, Q Tan - Diabetology & Metabolic …, 2020 - Springer
Type 2 diabetes mellitus (T2DM) is a complex polygenic metabolic disease characterized by
elevated blood glucose. Multiple environmental and genetic factors can increase the risk of …

The influence of SLC22A3 rs543159 and rs1317652 genetic variants on metformin therapeutic efficacy in newly diagnosed patients with type 2 diabetes mellitus: 25 …

R Taheri, F Kazerouni, R Mirfakhraei, S Kalbasi… - Gene, 2022 - Elsevier
Background and aims Among anti-diabetic medications, metformin has been proven to be
the preferred initial pharmacologic agent for type 2 diabetes mellitus (T2DM) treatment …

Identification of prognostic organic cation and anion transporters in different cancer entities by in silico analysis

B Edemir - International journal of molecular sciences, 2020 - mdpi.com
The information derived from next generation sequencing technology allows the
identification of deregulated genes, gene mutations, epigenetic modifications, and other …